Genetically Engineered E. Coli Platform:

• Utilizes Escherichia coli (E. coli) bacteria for biotechnological purposes.

• E. coli is chosen due to its well-studied nature, rapid growth, and genetic manipulability.

• Genetic engineering techniques modify E. coli strains to produce specific bio-products.

• Bio-products can include therapeutic proteins, enzymes, and biofuels.

Genetically Engineered Human Serum Albumin (HSA):

• HSA is a vital protein found in blood plasma with various medical applications.

• The process involves cloning the HSA gene into an expression system.

• Large-scale production occurs using bioreactors, ensuring consistent and safe HSA availability.

• HSA is used as a blood volume expander and in drug delivery.

Bioreactor for HSA Production:

• Bioreactors are specialized vessels for large-scale cultivation of microorganisms or cells.

• They provide a controlled environment for optimal cell growth and protein expression.

• Bioreactors ensure efficient and high-yield production of HSA.

• Crucial for biopharmaceutical manufacturing.

Vaccine Development:

• Focuses on designing, producing, and testing vaccines to prevent infectious diseases.

• Modern vaccine development often incorporates recombinant DNA technology.

• Vaccines stimulate the immune system to provide protection against specific pathogens.

• Crucial for public health and disease prevention.

Gene Therapy:

• Innovative field involving genetic modification within a patient’s cells.

• Aims to treat or prevent diseases by introducing, modifying, or deleting genetic material.

• Promising for various genetic disorders and certain types of cancer.

• Targets the molecular root causes of diseases.